Lars H. Lindner

Neo-adjuvant chemotherapy alone or with regional hyperthermia for localised high-risk soft-tissue sarcoma: a randomised phase 3 multicentre study

Rolf D. Issels, Lars H. Lindner, Jaap Verweij et al. · The Lancet Oncology · 2010 · 660 citations

Medicine, Clinical Sciences, Oncology +12

Overcoming Limitations in Nanoparticle Drug Delivery: Triggered, Intravascular Release to Improve Drug Penetration into Tumors

Ashley A. Manzoor, Lars H. Lindner, Chelsea D. Landon et al. · Cancer Research · 2012 · 455 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17

Effect of Neoadjuvant Chemotherapy Plus Regional Hyperthermia on Long-term Outcomes Among Patients With Localized High-Risk Soft Tissue Sarcoma

Rolf D. Issels, Lars H. Lindner, Jaap Verweij et al. · JAMA Oncology · 2018 · 322 citations · Full text

Medicine, Oncology, Chemotherapy +16

Novel Temperature-Sensitive Liposomes with Prolonged Circulation Time

Lars H. Lindner, Martin Eichhorn, Hansjoerg Eibl et al. · Clinical Cancer Research · 2004 · 257 citations

Pharmacy, Oncology, Pharmacology +14

Hyperthermia and Thermosensitive Liposomes for Improved Delivery of Chemotherapeutic Drugs to Solid Tumors

Gerben A. Koning, Alexander M.M. Eggermont, Lars H. Lindner et al. · Pharmaceutical Research · 2010 · 253 citations · Full text

Pharmacy, Oncology, Pharmaceutics +17